Artigo
Revisado por pares
Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide + methotrexate + fluorouracil in patients with node-positive breast cancer
1996; Springer Science+Business Media; Volume: 51; Issue: 2 Linguagem: Inglês
10.1007/s002280050169
ISSN1432-1041
AutoresAndrea Messori, Paola Becagli, Sabrina Trippoli, Enrico Tendi,
Tópico(s)Health Systems, Economic Evaluations, Quality of Life
Referência(s)